Key Financial Data Of Group

STELLA PHARMA CORPORATION - Filing #7320249

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
Key financial data of group
Business results of group
Net sales
269,491,000 JPY
229,067,000 JPY
100,096,000 JPY
205,968,000 JPY
JPY
Ordinary profit (loss)
-760,208,000 JPY
-775,974,000 JPY
-764,088,000 JPY
-656,392,000 JPY
-959,351,000 JPY
Net assets
2,377,012,000 JPY
2,752,502,000 JPY
3,079,623,000 JPY
230,718,000 JPY
690,033,000 JPY
Total assets
3,820,622,000 JPY
4,329,053,000 JPY
4,718,649,000 JPY
2,048,524,000 JPY
2,660,006,000 JPY
Net assets per share
75.90
91.51
107.39
11.46
34.57
Basic earnings (loss) per share
-24.66
-26.97
-27.34
-32.90
-61.68
Diluted earnings per share
Equity-to-asset ratio
0.6203 xbrli:pure
0.6335 xbrli:pure
0.6526 xbrli:pure
0.1126 xbrli:pure
0.2594 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-876,837,000 JPY
-827,669,000 JPY
-1,081,129,000 JPY
-772,811,000 JPY
-913,583,000 JPY
Net cash provided by (used in) investing activities
-9,010,000 JPY
-29,925,000 JPY
-350,562,000 JPY
-22,864,000 JPY
1,557,990,000 JPY
Net cash provided by (used in) financing activities
228,353,000 JPY
291,819,000 JPY
3,829,240,000 JPY
-332,402,000 JPY
-68,579,000 JPY
Cash and cash equivalents
2,012,233,000 JPY
2,669,727,000 JPY
3,235,502,000 JPY
837,952,000 JPY
1,966,030,000 JPY
Number of employees
44 xbrli:pure
46 xbrli:pure
43 xbrli:pure
43 xbrli:pure
42 xbrli:pure
Average number of temporary employees
5 xbrli:pure
3 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.